Analyst Ratings for Royalty Pharma (RPRX)
RPRX Rating Summary
RPRX Price Target Summary
- Highest: $56.00 (SunTrust)
- Lowest: $50.00 (Citi)
- Average: $52.38
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$52.38 (+19%)
* Over Last 12-Mos
Rating Score: 5 / 10
Percentile Rank: 50%
Avg. $ Target:
$52.38 (+19%)
* Over Last 12-Mos
Rating Score: 5 / 10
Percentile Rank: 50%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/9/2020 | UBS » Updated 3/19/2021 |
Navin Jacob | Upgrade | Buy (Neutral) |
52.00 (51.00) |
40.13 (44.02) |
9.69% | Details |
| 7/14/2020 | Evercore ISI | Umer Raffat | New Coverage | In Line (N/A) |
N/A (N/A) |
47.64 (44.02) |
-7.6% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
